Suppr超能文献

对男同性恋者进行的HTLV-III/LAV感染的三年前瞻性研究。

Three-year prospective study of HTLV-III/LAV infection in homosexual men.

作者信息

Weber J N, Wadsworth J, Rogers L A, Moshtael O, Scott K, McManus T, Berrie E, Jeffries D J, Harris J R, Pinching A J

出版信息

Lancet. 1986 May 24;1(8491):1179-82. doi: 10.1016/s0140-6736(86)91160-8.

Abstract

170 symptom-free homosexual men were recruited in London in 1982-83 and 133 were evaluable in 1983-85. Of the 33 who were seropositive to HTLV-III/LAV at entry, 4 (12%) progressed to AIDS, 16 (48%) progressed to persistent generalised lymphadenopathy (PGL), and 13 (40%) remained symptom-free. A further 15 men seroconverted during the study (7% per annum), of whom 8 progressed to PGL. Serial estimations of T lymphocyte subsets showed progressive reduction in T4 numbers in the seropositive groups, but these indices also varied widely in the seronegative group. Counts of T4 and T8 cells or T4/T8 ratio at entry were not of prognostic value. Seronegative subjects were as likely as seropositives to have abnormal immunological tests. Serial measurement of T lymphocyte subsets seems to be of little prognostic or clinical value in the monitoring of populations infected with the HTLV-III/LAV virus. The strongest association with prognosis was an episode of sexually transmitted disease in the six months before entry to the study. This supports the hypothesis that intercurrent infection may be an important co-factor in the acquisition of HTLV-III/LAV infection, and in subsequent disease progression.

摘要

1982年至1983年期间,在伦敦招募了170名无症状同性恋男性,1983年至1985年期间有133人可进行评估。在入组时HTLV-III/LAV血清学呈阳性的33人中,4人(12%)进展为艾滋病,16人(48%)进展为持续性全身性淋巴结肿大(PGL),13人(40%)仍无症状。在研究期间,另有15名男性发生血清转化(每年7%),其中8人进展为PGL。对T淋巴细胞亚群的系列评估显示,血清学阳性组中T4细胞数量逐渐减少,但这些指标在血清学阴性组中也有很大差异。入组时T4和T8细胞计数或T4/T8比值无预后价值。血清学阴性受试者与血清学阳性受试者一样,免疫检测结果也可能异常。在监测感染HTLV-III/LAV病毒的人群时,对T淋巴细胞亚群的系列测量似乎几乎没有预后或临床价值。与预后最强的关联是在入组研究前六个月发生的性传播疾病。这支持了一种假设,即并发感染可能是获得HTLV-III/LAV感染以及随后疾病进展的重要协同因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验